Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia.

David W. Lee(Phoenix Children's Hospital), R.J. Arceci(Johns Hopkins University), Kejian Zhang(Cincinnati Children's Hospital Medical Center), Benjamin J. Wilkins(Children's Hospital of Philadelphia), Eric H. Raabe(Johns Hopkins University), Ruthann I. Blough(University of Cincinnati Medical Center), Zhi Qiang Ning(University of Cincinnati Medical Center), Regina Wieland(Essen University Hospital), Julia M. Kim(Johns Hopkins University), Suzanne Tintner(University of Cincinnati Medical Center)
PubMed
July 1, 2000
Cited by 72

Related Papers

Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427
The multidrug resistance (mdr1) gene product functions as an ATP channel.
|Proceedings of the National Academy of Sciences|1993|372
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
|Science Translational Medicine|2019|259
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
|Blood|2011|230